Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

This activity was originally broadcast in conjunction with AMCP 2025.

Program Description

HIV is a chronic condition affecting over 1 million people in the United States, and many people living with HIV experience systemic barriers to care that limit treatment access and adherence. Long-acting injectables (LAIs) have extended the administration schedule for antiretroviral regimens, but challenges in the management of these therapies still remain. Pharmacists practicing in managed care can be central to identifying people with increased risk behaviors for HIV transmission, reviewing evidence-based recommendations for inclusion of LAIs within formularies and treatment protocols, and monitoring for treatment adherence and efficacy. Additionally, ensuring that people who are eligible for preexposure prophylaxis (PrEP) requires that managed care professionals and pharmacists implement projects designed to improve the uptake of PrEP LAIs. This session will review key aspects of improving access and adherence to LAIs, including programs emphasizing equitable implementation in HIV care and real-time decision-making with patients. Detailed information on the route of administration and dosing schedules for LAIs and how they can be effectively incorporated into HIV care plans will also be discussed.

Target audience: Managed care pharmacists

Type of activity: Application
Release date: April 9, 2025
Expiration date: April 9, 2026

Time to complete activity: 1.5 hours

Learner level: Intermediate
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Identify patient populations who may benefit from HIV long-acting injectables (LAIs) based on clinical guidelines, risk factors, and patient preferences.
• Differentiate between the various HIV LAIs available, including their mechanisms of action, dosing regimens, and appropriate indications for use.
• Apply managed care strategies to optimize the uptake of HIV LAIs among eligible patients, including coverage policies, patient education, and provider engagement initiatives.